Search research articles
Contact Us
Filters
Showing results (101-110 of 128) with videos related to
Page
of 13
Sort By:
Blood Advances
|
February 5, 2025
Phase 2 trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomas
Dai Chihara, Raphael E Steiner, Ranjit Nair, et al.
Blood Advances
|
September 25, 2024
Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature
Côme Bommier, Brian K Link, Brianna J Gysbers, et al.
Plos One
|
March 15, 2018
The risk of central nervous system relapses in patients with peripheral T-cell lymphoma
Dai Chihara, Michelle A Fanale, Roberto N Miranda, et al.
Frontiers in Oncology
|
September 26, 2024
Outcomes and toxicities in patients with diffuse-large B cell lymphoma involving the gastrointestinal tract and digestive organs
Gohar S Manzar, Elaine E Cha, Kelsey L Corrigan, et al.
Blood Cancer Journal
|
July 2, 2026
Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma
Karan L Chohan, Eduardo Edelman Saul, R Eric Davis, et al.
Haematologica
|
November 30, 2023
Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma
Matthew J Maurer, Carla Casulo, Melissa C Larson, et al.
Blood Advances
|
November 27, 2024
Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO Consortium
Jonathan R Day, Melissa C Larson, Urshila Durani, et al.
British Journal of Haematology
|
December 17, 2016
The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma
Dai Chihara, Michelle A Fanale, Roberto N Miranda, et al.
JAMA Network Open
|
April 7, 2025
Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy
James P Long, Rishab Prakash, Paul Edelkamp, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 20, 2024
Characterization of Lymphopenia and Correlating the Risk of Cytopenias With Dose and Bone Marrow Volume Irradiated in Aggressive B Cell Lymphoma Patients Bridged With Radiation Therapy for Chimeric Antigen Receptor-T Cell Therapy
Gohar S Manzar, Susan Y Wu, Stephanie O Dudzinski, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 128) with videos related to
Sort By:
Page
of 13
Blood Advances
|
February 5, 2025
Phase 2 trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomas
Dai Chihara, Raphael E Steiner, Ranjit Nair, et al.
Blood Advances
|
September 25, 2024
Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature
Côme Bommier, Brian K Link, Brianna J Gysbers, et al.
Plos One
|
March 15, 2018
The risk of central nervous system relapses in patients with peripheral T-cell lymphoma
Dai Chihara, Michelle A Fanale, Roberto N Miranda, et al.
Frontiers in Oncology
|
September 26, 2024
Outcomes and toxicities in patients with diffuse-large B cell lymphoma involving the gastrointestinal tract and digestive organs
Gohar S Manzar, Elaine E Cha, Kelsey L Corrigan, et al.
Blood Cancer Journal
|
July 2, 2026
Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma
Karan L Chohan, Eduardo Edelman Saul, R Eric Davis, et al.
Haematologica
|
November 30, 2023
Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma
Matthew J Maurer, Carla Casulo, Melissa C Larson, et al.
Blood Advances
|
November 27, 2024
Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO Consortium
Jonathan R Day, Melissa C Larson, Urshila Durani, et al.
British Journal of Haematology
|
December 17, 2016
The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma
Dai Chihara, Michelle A Fanale, Roberto N Miranda, et al.
JAMA Network Open
|
April 7, 2025
Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy
James P Long, Rishab Prakash, Paul Edelkamp, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 20, 2024
Characterization of Lymphopenia and Correlating the Risk of Cytopenias With Dose and Bone Marrow Volume Irradiated in Aggressive B Cell Lymphoma Patients Bridged With Radiation Therapy for Chimeric Antigen Receptor-T Cell Therapy
Gohar S Manzar, Susan Y Wu, Stephanie O Dudzinski, et al.
Page
of 13